Study Group: Ranexa Prescribers for Angina: Cardiologists (US)(?)
Council Members in this Study Group: 82
Request a survey with this Study Group
Leading Experts in this Study Group
Professor of Medicine
Finch University of Health Science-Chicago Medical School
Rohit Arora, MD, FACC, FAHA, FASCI, FACP, is a Professor of Medicine and Professor of Physiology and Biophysics at Chicago Medical School, Illinois. He is also the Chairman of Cardiology and Associate Chairman of Medicine in the Department of Medicine. Dr. Arora is also Chief of Cardiology at the North...
Clinical Director
NYU Medical Center
Howard Weintraub, MD, FACC, is the Clinical Director of Center for the Prevention of Cardiovascular Disease at NYU Medical Center. He has been a consultant for several organizations and has been a Cardiologist for the National Football League. Dr. Weintraub has written textbook chapters on evaluation...
Hossein Ardehali, MD, PhDAssistant Professor
Feinberg School of Medicine, Northwestern University
Hossein Ardehali, MD, PhD, is an Assistant Professor of Medicine at Feinberg Cardiovascular Institute in Illinois. His specialties include lipid metabolism, preventive cardiology, electrophysiology and heart failure. Dr. Ardehali's basic science research interest is in the areas of reperfusion injury...
Owner
Joshua M. Feuer, MD
Joshua Feuer, MD, FACC, is a board certified Cardiologist in private practice in Santa Barbara, California. He also serves as a Consulting Cardiologist at Santa Barbara Cottage Hospital. Dr. Feuer specializes in aggressive preventive cardiology and cardiovascular risk assessment, and reduction. He has...
Bernard Chaitman, MDProfessor and Director
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE
Bernard Chaitman, MD, is a Professor of Internal Medicine and Director of Cardiovascular Research at St. Louis University School of Medicine, Missouri. He is also the Director of Core ECG Laboratory. Dr. Chaitman has research interests in anti-anginal drug therapies including Ranolazine, Nicorandil,...
Director of Cardiac Catheterization Lab
Wadsworth VA Medical Center
Ramin Ebrahimi, MD, is an Associate Clinical Professor at the University of California, Los Angeles. He is also the Director of the Cardiac Catheterization Laboratory and Assistant Director of Nuclear Cardiology at the Wadsworth VA Medical Center. Dr. Ebrahimi’s clinical and research interests focus...
Samuel Butman, MDInterventional Cardiologist
Verde Valley Heart LLC
Samuel Butman, MD, is an Interventional Cardiologist at Verde Valley Medical Center. Dr. Butman is also a Clinical Associate Professor of Medicine at University Medical Center in Tucson, Arizona. He has also served as the Director of Cardiology Interventional Fellows Program and Director of Cardiac...
Barry Massie, MDChief of the Cardiology Division
San Francisco Veterans Affairs Medical Center
Barry Massie, MD, is a Professor of Medicine at the University of California at San Francisco and also the Chief of Cardiology Division at San Francisco Veterans Affairs Medical Center. Dr. Massie is an expert in the areas of heart failure, hypertension, cardiovascular therapeutics, and is involved...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Non-Electrophysiologist Cardiologists (US) | 832 |
| Heart Failure Specialists (US) | 849 |
| Physicians who Treat Hypertension (US) | 664 |
| General Cardiologists (US) | 1333 |
| Cardiologists who Treat Angina (US) | 112 |
| Interventional Cardiologists (US) | 428 |
| Niaspan Prescribers for Raising HDL | 142 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
It is well known that the addition of thiazide diuretic to ACEI or ARB treatment adds about 10 mm Hg reduction on top of the 10 mm Hg reduction provided by the ACEI or ARB agent. It is expected that blocking renin in the renin angiotensin system with Tekturna would provide a similar result.
The treatment of hyperlipidemia has profound repercussions on cardiovascular disease. The market is huge. I hear that there were 35 million prescriptions for ezetimibe products last year. Although the epidemiological association between LDL and cardiac risk is strong, LDL is an imperfect surrogate for...
Patients with rare malignancies, especially those with already metastatic diseases, are being treated with novel oncologic agents. However, as is being seen with many drugs, the hemodynamic consequences of these agents, in many cases a rise in blood pressure, may lead to cardiovascular consequences. ...
I anticipate vytorin and zetia sales will be down substantial when the IMS numbers come out tommorrow, but that this will be only the beginning of a negative trend for these scripts. I list below several reasons why.
TRITON-TIMI 38 study of 13,608 patients with ACS compared prasugrel against clopidogrel, combined with aspirin. Prasugrel reduced the combined rate of CV death, MI or stroke (12.1% for clopidogrel vs. 9.9% for prasugrel). The benefit came at a cost of increased serious bleeding (1.4%, vs....
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Government/Military Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Partner
- Owner
- Physician - Division Head
- President
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms